The global dental biomaterials market was valued at US$ 7.96 billion in 2021 and is expected to hit US$ 13.6 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.8% from 2022 to 2030.
The factors such as growing geriatric population, surge in number of dental implants, and rising dental disorders are driving the demand for dental biomaterials in the global market. One of the main concerns among people is regarding tooth decay and dental caries. Dental caries afflicted 3.58 billion people worldwide in 2016, as per the World Health Organization (WHO).
Report Scope of the Dental Biomaterials Market
|Market Size by 2030
||USD 13.6 Billion
|Growth Rate from 2022 to 2030
||CAGR of 6.8%
|North America Market Share in 2021
|Dental Laboratories Segment Market Share in 2021
||2022 to 2030
||Type, Application, End Use, Bone Graft Material Type, Geography
||3M Company, Bego Medical GmbH, Carpenter Technology Corporation, Danaher Corporation, Datum Dental Ltd., GC Corporation, Henry Schein Inc., IvoclarVivadent AG, Keystone Dental Inc., Medtronic PLC
The metallic biomaterials segment dominated the dental biomaterials market in 2021. The ceramic dental biomaterials segment is growing due to the rising trend of dental implants and surgeries.
The composite biomaterials segment is expected to witness strong growth from 2022 to 2030.
The orthodontics segment accounted largest revenue share 43% in 2021. The demand for dental biomaterials in orthodontics is growing due to the surge in number of dental disorders and tooth decays.
North America dominated the dental biomaterials market in 2021 and garner revenue share of around 37%. One of the key factors driving the growth of dental biomaterials market in North America region is growing dental disorders. According to the American Dental Association 2020, over 5 million Americans aged 65 to 74 have lost all of their teeth, including approximately 3 million edentulous.
- In 2018, The Straumann Group paid an unspecified price for a 30% investment in Botiss Medical AG, a biomaterials collaborator. Straumann will be able to increase its dental biomaterials portfolio as a result of this strategy.
- MTApexbioceramic root canal sealer, a new endodontic solution from Ultradent Products Inc. was launched in February 2022. MTApex is a bioceramic sealer that may be utilized with any endodontic obturation technique.
- Carpenter Technology Corporation declared the expansion of its Alabama Campus Emerging Technology in 2018.
- Botiss Biomaterials GmbH announced the development of the next generation of dental biomaterials in August 2021.
Some of the prominent players in the global dental biomaterials market include:
Bego Medical GmbH
Carpenter Technology Corporation
Datum Dental Ltd.
Henry Schein Inc.
Keystone Dental Inc.